Cabozantinib plus atezolizumab showed promising antitumour activity in patients with metastatic castration-resistant prostate cancer after novel hormonal therapy with an acceptable safety profile, supporting further evaluation of this combination.
COSMIC-021 trial: Cabozantinib plus... - Advanced Prostate...
COSMIC-021 trial
Written by
spw1
To view profiles and participate in discussions please or .
Read more about...
Not what you're looking for?
You may also like...
ARASENS Trial
I am Hormone sensitive so far
Currently on Lupron and Zytiga,
is Darolutamide significantly...
Stampede Trial?
Burnett1948. Does anybody know about what the Stampede trial and how many extra years Chemo with...
psmaAddition trial
is this new clinical trial looking to see how adding pluvicto to SOC works for naive hormone...
splash trial
my husband and I are running into an odd situation with the splash trial. He is in the control arm...
JANX007 Trial
Hello all,It has been a while since I last updated my status on the trial of this new drug. I...
TRC253 Trial
Dynamo Trial
BAT trial
Psilocybin clinical trial 
Keytruda /Xtandi trial 
